ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,171, issued on Dec. 9, was assigned to Vettore LLC (San Francisco).
"Heterocyclic inhibitors of MCT4" was invented by Kenneth Mark Parnell (Kaysville, Utah), John McCall (Boca Grande, Fla.) and Donna Romero (Chesterfield, Mo.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds and compositions useful in the treatment of MCT4 mediated diseases, such as proliferative and inflammatory diseases, having the structure of Formula I:Methods of inhibition MCT4 activity in a human or animal subject are also provided."
The patent was filed on Feb. 22, 2022, under Application No. 17/652,022.
*For further information, including images,...